The relationship between degree of anemia and lipid metabolsm

Results: The mean levels of total and low density li-poprotein (LDL) cholesterol of anemic women were lower than those of nonanemic controls (172.86+/-38.09 vs 207.60+/-35.90 mg/dL, p=0.001,105.02+/-32.02 vs 137.00+/-31.42 mg/dL, p

📌 3 Key Takeaways

🎯

Objective & Hypothesis:To investigate the relationship between degree of anemia and lipid metabolism in premenopausal women in whom iron deficiency anemia is not uncommon.

📊

Key Findings & Data:Methods: This prospective cohort study was carried out with 58 premenopausal women (median age of 40 years, ranging from 15 to 51) with iron deficiency anemia due to menstrual loss and 20 nonanemic control women (median age of 38 years, ranging from 28 to 50).

💡

Conclusion & Impact:Results: The mean levels of total and low density li-poprotein (LDL) cholesterol of anemic women were lower than those of nonanemic controls (172.86+/-38.09 vs 207.60+/-35.90 mg/dL, p=0.001,105.02+/-32.02 vs 137.00+/-31.42 mg/dL, p

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

To investigate the relationship between degree of anemia and lipid metabolism in premenopausal women in whom iron deficiency anemia is not uncommon. Methods: This prospective cohort study was carried out with 58 premenopausal women (median age of 40 years, ranging from 15 to 51) with iron deficiency anemia due to menstrual loss and 20 nonanemic control women (median age of 38 years, ranging from 28 to 50). Serum ferritin values less than 11 ng/mL and transferin saturation below 15% were accepted as indicators of iron deficiency. All anemic patients were treated with oral iron replacement. All anemic patients were dichotomised by median for pre-treatment hemoglobin (Hb) levels ( 9.63 g/dL) to assess the effect of the degree of anemia on the relationship between iron deficiency anemia and lipid metabolism. Results: The mean levels of total and low density li-poprotein (LDL) cholesterol of anemic women were lower than those of nonanemic controls (172.86+/-38.09 vs 207.60+/-35.90 mg/dL, p=0.001,105.02+/-32.02 vs 137.00+/-31.42 mg/dL, p

Özet

Amaç: Demir eksikliği anemisinin sık görüldüğü pre-menopozal kadınlarda aneminin derecesi ile lipid meta-bolizmasf arasındaki ilişkinin araştırılması. Metod: Bu prospektif cohort çalışma menstrual kayıptan dolayı demir eksikliği anemisi olan 58 premenopo-zal kadın (ortalama yaş 40 yıl, oran 15-51) ve 20 nona-nemik control kadında (ortalama yaş 38 yıl, oran 28-50) yapıldı. 11 ng/mL'nin altında serum ferritin değeri ve %15'in altında transferring satürasyonu demir eksikliğinin göstergeleri olarak kabul edildi. Tüm anemic hastalar oral demir verilerek tedavi edildi. Demir eksikliği anemisi ile lipid metabolizması arasındaki ilişkide aneminin derecesinin rolünü araştırmak için anemic hastalar tedavi öncesi hemoglobin (Hb) seviyesi median değere gore ( 9.63 g/dL) iki alt gruba ayrıldı. Sonuçlar: Anemik kadınların ortalama total ve düşük dansiteli lipoprotein (LDL) kolesterol seviyeleri nonane-mik kontrollerden anlamlı olarak daha düşüktü (sırasıyla, 172.86+/-38.09 vs 207.60+/-35.90 mg/dL, p=0.001, 105.02+/-32.02 vs 137.00+/-31.42 mg/dL, p

🔖

Cite This Article

SEVİNÇ, C., BAYOĞLU, V., ERSOY, E., ÖZDEMİR, A., TÜRKMEN, F., IŞIK, E. (2022). The relationship between degree of anemia and lipid metabolsm. Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 48 - Sayı: 1, 3–7. https://ajindex.com/articles/535521

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (1)

Tanzer F, Hizel S, Cetinkaya O, et al.: Serum free carnitine and total triglycerid levels in children with iron deficiency anemia. Int J Vitam Nutr Res. 2001 Jan;71(1):66-9. 2.Choi JW, Kim SK, Pal SH.: Changes in serum lipid concentrations during iron depletion and after iron supplementation. Ann Clin LabSci.2001Apr;31(2):151-6. 3.Ohira Y, Edgerton VR, Gardner GW, et al.: Serum lipid levels in iron deficiency anemia and effects of various treatments. J Nutr Sci Vitaminol (Tokyo). 1980;26(4):375-9. 4.Sherman AR.: Serum lipids in suckling and post-weanling iron-deficient rats. Lipids. 1979 Nov;14(11):888-92. 5.You SA, Wang Q.: Ferritin in atherosclerosis. Clin Chim Ada. 2005 Jul 1;357(1):1-16. 6.Qayyum R, Schulman P.: Iron and atherosclerosis. Clin Cardiol. 2005 Mar;28(3):119-22. 7.Minqin R, Rajendran R, Pan N, at al.: The iron chelator desfer rioxamine inhibits atherosclerotic lesion development and decreases lesion iron concentrations in the cholesterol-fed rabbit. Free Radic Biol Med. 2005 May 1;38(9):1206-11. 8.Sengoelge G, Sunder-Plassmann G, Horl WH.: Potential risk for infection and atherosclerosis due to iron therapy. J Ren Nutr. 2005 Jan;15(1):105-10. 9.Kruszewski M.: The role of labile iron pool in cardiovascular diseases. Acta Biochim Pol. 2004;51(2):471-80. 10.Yuan XM, Li W.: The iron hypothesis of atherosclerosis and its clinical impact. Ann Med. 2003;35(8):578-91. 11.Zheng H, Cable R, Spencer B, et al.: Iron stores and vascular function in voluntary blood donors. Arterioscler Thromb Vase Biol. 2005 Aug;25(8):1577-83.